日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrative bioinformatics and experiments identify RIBC2 as a key regulator in the esophageal cancer.

整合生物信息学和实验表明,RIBC2 是食管癌的关键调控因子。

Zheng Xuan, Cui Yishuang, Yao Xuemin, Wu Yanan, Ge Yanlei, Jin Ye, Gan Junqing, Yao Weinan, Bi Yanna, Sun Guogui

Mechanism of action for Troxerutin targeting the sialylation-related gene EGLN3 for the treatment of LUAD.

Troxerutin 的作用机制是靶向唾液酸化相关基因 EGLN3 治疗 LUAD

Wu Yanan, Ge Yanlei, Gan Junqing, Jin Ye, Cui Yishuang, Zheng Xuan, Yao Xuemin, Sun Guogui

RHBDF1 modulates cisplatin sensitivity of small cell lung cancer through YAP1/Smad2 signaling pathway

RHBDF1通过YAP1/Smad2信号通路调节小细胞肺癌对顺铂的敏感性

Wang, Lei; Qi, Lishuang; Huang, Xiaoyi; Feng, Xiao; Gan, Junqing; Zhang, Juxuan; Xi, Yuhui; Zhang, Shuai; Meng, Qingwei

Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report

同步性双原发性小细胞肺癌和浸润性导管癌:病例报告

Gan, Junqing; Liu, Meiyue; Liu, Fei; Wen, Junxiu; Fu, Wenjuan; Jia, Jinghao

[Isoliquiritigenin Modulates the Effect of LINC01503 
on Lung Squamous Carcinoma Cells]

异甘草素调节LINC01503对肺鳞状细胞癌细胞的作用

Zhang, Mengshi; Cui, Yishuang; Yao, Yihan; Ge, Yanlei; Gan, Junqing; Jin, Ye; Sun, Guogui

Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer

通过多组学整合分析,鉴定出EFNA家族在泛癌中的表达特征、免疫标志和预后价值

Jiao, Zonglin; Feng, Xiao; Cui, Yuqing; Wang, Lei; Gan, Junqing; Zhao, Yanbin; Meng, Qingwei

Pyroptosis, a new bridge to tumor immunity

细胞焦亡:通往肿瘤免疫的新桥梁

Li, Lisha; Jiang, Mingxia; Qi, Ling; Wu, Yiming; Song, Dongfeng; Gan, Junqing; Li, Yanjing; Bai, Yuxian

CMD-05, a novel promising clinical anti-diabetic drug candidate, in vivo and vitro studies

CMD-05,一种有前景的新型临床抗糖尿病候选药物,体内和体外研究

Jie Ma, Huan Li, Xiangnan Hu, Lu Yang, Qi Chen, Congli Hu, Zhihao Chen, Xiaoyan Tian, Yang Yang, Ying Luo, Run Gan, Junqing Yang